Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)
HKD 11.12
(0.18%)
HKD 11.12
(0.18%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 384.98 Million CNY | 52.37% |
| 2022 | 252.66 Million CNY | 91.59% |
| 2021 | 131.88 Million CNY | 709.73% |
| 2020 | 16.28 Million CNY | 1266.36% |
| 2019 | 1.19 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 130.45 Million CNY | 0.0% |
| 2024 Q1 | 130.45 Million CNY | 21.73% |
| 2023 FY | 384.98 Million CNY | 52.37% |
| 2023 Q2 | 85.32 Million CNY | 0.0% |
| 2023 Q4 | 107.17 Million CNY | 0.0% |
| 2023 Q1 | 85.32 Million CNY | 24.38% |
| 2023 Q3 | 107.17 Million CNY | 25.61% |
| 2022 Q2 | 57.73 Million CNY | 0.0% |
| 2022 FY | 252.66 Million CNY | 91.59% |
| 2022 Q3 | 68.59 Million CNY | 18.8% |
| 2022 Q1 | 57.73 Million CNY | 44.79% |
| 2022 Q4 | 68.59 Million CNY | 0.0% |
| 2021 Q3 | 39.87 Million CNY | 53.01% |
| 2021 Q2 | 26.06 Million CNY | 0.0% |
| 2021 FY | 131.88 Million CNY | 709.73% |
| 2021 Q4 | 39.87 Million CNY | 0.0% |
| 2021 Q1 | 26.06 Million CNY | 231.83% |
| 2020 FY | 16.28 Million CNY | 1266.36% |
| 2020 Q3 | 7.85 Million CNY | 2612.95% |
| 2020 Q1 | 289.5 Thousand CNY | 0.0% |
| 2020 Q2 | 289.5 Thousand CNY | 0.0% |
| 2020 Q4 | 7.85 Million CNY | 0.0% |
| 2019 FY | 1.19 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 222.59 Million HKD | -72.958% |